Company / Interest Expense per Share
Royalty Pharma plc Interest Expense per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.45
FY2023
5-year range
$0.42 / $0.72
FY2020-FY2023
Trend
+7.9%
vs FY2022
Sector context
#12 of 43
Health Care
What the data says
At $0.45, Royalty Pharma plc's interest expense per share ranks #32 of 43 in the Health Care sector. Interest Expense per Share returned to growth in FY2023 after 2 years of decline, reaching $0.45.
Based on SEC 10-K filings.
0.45 in FY2023 with a 3-year CAGR of -15.4%.
Improved from $0.72 to $0.45 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -15.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#32 of 43 in Health CareTop 72% of 43This company $0.45 Sector average $9.80
▼
-95.4% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 7.9% year-over-year.
- Ranks #12 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.45 | +7.9% |
| FY2022 | $0.42 | -41.5% |
| FY2021 | $0.72 | -4.1% |
| FY2020 | $0.75 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026